Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: A meta-analysis
Authors:
- Claudia MarchettiCMClaudia Marchetti
- Francesca De FeliceFFFrancesca De Felice
- Giorgia PerniolaGPGiorgia Perniola
- Innocenza PalaiaIPInnocenza Palaia
- Angela MusellaAMAngela Musella
- Violante Di DonatoVDViolante Di Donato
- Ludovico MuziiLMLudovico Muzii
- Vincenzo TomboliniVTVincenzo Tombolini
- Pierluigi Benedetti PaniciPPPierluigi Benedetti Panici
- 1 April 2019
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 136, 64-69
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group StudyBritish Journal of Cancer, 2013
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian CancerNew England Journal of Medicine, 2010
- Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian CancerJournal of Clinical Oncology, 2010
- Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancerGynecologic Oncology, 2009
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Intraperitoneal cisplatin‐based chemotherapy vs. intravenous cisplatin‐based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancerInternational Journal of Gynecology & Obstetrics, 2001
- Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian CancerNew England Journal of Medicine, 1996
- A Comparison of Intravenous versus Intraperitoneal Chemotherapy for the Initial Treatment of Ovarian CancerGynecologic Oncology, 1994